Myelodysplasia and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy

被引：0

作者：

Freedman, MH

Bonilla, MA

Fier, C

Bolyard, AA

Scarlata, D

Boxer, LA

Brown, S

Cham, B

Kannourakis, G

Kinsey, SE

Mori, PG

Cottle, T

Welte, K

Dale, DC

机构：

[1] Univ Washington, Severe Chron Neutropenia Int Registry, Seattle, WA 98195 USA

[2] Med Hsch Hannover, Hannover, Germany

[3] Amgen Inc, Clin Safety, Boulder, CO USA

来源：

LEUKEMIA | 2000年 / 14卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：964 / 964

页数：1

共 50 条

[31] G-CSF THERAPY, CONGENITAL NEUTROPENIA AND THE DEVELOPMENT OF MYELODYSPLASTIC SYNDROME WITH MONOSOMY-7 [J].

ALHASHMI, I ;

WANG, H ;

SAUNDERS, EF ;

ZIPURSKY, A ;

FREEDMAN, MH .

BLOOD, 1993, 82 (10) :A551-A551

[32] Severe Congenital Neutropenia with ELANE gene mutation, on G-CSF therapy; a case report [J].

Hanan, A. ;

Altaf, S. ;

Safdar, J. ;

Khan, A. ;

Sheikh-Fayyaz, S. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 :S97-S97

[33] Frequency of point mutations in the gene for the G-CSF receptor in patients with chronic neutropenia undergoing G-CSF therapy - Discussion [J].

Fibbe ;

Welte ;

Lowenberg ;

Ihle .

STEM CELLS, 1997, 15 :120-120

[34] Structural abnormalities in the G-CSF receptor in severe congenital neutropenia [J].

Deshpande, RV ;

Lalezari, P ;

Pergolizzi, RG ;

Moore, MAS .

JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 1999, 8 (04) :411-420

[35] The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemia [J].

Kutlay, S ;

Beksac, M ;

Dalva, K ;

Ilhan, O ;

Koc, H ;

Akan, H ;

Ozcan, M .

LEUKEMIA & LYMPHOMA, 2003, 44 (05) :791-795

[36] G-CSF after intensive consolidation chemotherapy in acute myeloid leukemia (AML). [J].

Harousseau, JL ;

Witz, F ;

Desablens, B ;

Leprise, PY ;

Francois, S ;

Delain, M ;

Abgrall, JF ;

Solary, E .

BLOOD, 1997, 90 (10) :2249-2249

[37] G-CSF-receptor mutations are not the cause of congenital neutropenia but increase the risk of developing acute myeloid leukemia. [J].

Tidow, N ;

Teichmann, B ;

Pilz, C ;

Kasper, B ;

Germeshausen, M ;

Welte, K .

EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) :268-268

[38] POINT MUTATIONS IN THE G-CSF-R GENE IN SEVERE CONGENITAL NEUTROPENIA TERMINATING IN ACUTE MYELOID-LEUKEMIA [J].

TOUW, IP ;

SCHELEN, A ;

BRYNES, RK ;

TIDOW, N ;

WELTE, K ;

LOWENBERG, B ;

DONG, F .

BLOOD, 1994, 84 (10) :A375-A375

[39] MYELODYSPLASIA AND LEUKEMIA AFTER TREATMENT OF APLASTIC-ANEMIA WITH G-CSF [J].

KOJIMA, S ;

TSUCHIDA, M ;

MATSUYAMA, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) :1294-1295

[40] Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy [J].

Rosenberg, Philip S. ;

Zeidler, Cornelia ;

Bolyard, Audrey A. ;

Alter, Blanche P. ;

Bonilla, Mary A. ;

Boxer, Laurence A. ;

Dror, Yigal ;

Kinsey, Sally ;

Link, Daniel C. ;

Newburger, Peter E. ;

Shimamura, Akiko ;

Welte, Karl ;

Dale, David C. .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) :196-199

← 1 2 3 4 5 →